Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Saxagliptin
Drug ID BADD_D01992
Description Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.
Indications and Usage Treatment of type 2 diabetes mellitus to improve glycemic control in combination with other agents or as monotherapy.
Marketing Status Prescription
ATC Code A10BH03
DrugBank ID DB06335
KEGG ID D08996
MeSH ID C502994
PubChem ID 11235729
TTD Drug ID D0K9MY
NDC Product Code 0310-6105; 55154-6931; 11722-078; 0310-6100; 50370-0030; 50193-4212
Synonyms saxagliptin | 3-hydroxyadamantylglycine-4,5-methanoprolinenitrile hydrate | Onglyza | BMS 477118 | BMS477118 | BMS-477118
Chemical Information
Molecular Formula C18H25N3O2
CAS Registry Number 361442-04-8
SMILES C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Cardiac failureDipeptidyl peptidase 4P27487T3139125453730
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.0010.001500%
Abdominal pain07.01.05.0020.005251%
Abdominal pain upper07.01.05.0030.003751%
Acidosis14.01.03.0020.001500%
Acute abdomen07.01.06.0150.001500%Not Available
Acute myocardial infarction24.04.04.001; 02.02.02.0010.000783%Not Available
Alanine aminotransferase increased13.03.01.0030.001500%
Amylase increased13.05.01.0090.002251%
Anaemia01.03.02.001--
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angioedema23.04.01.001; 10.01.05.0090.003001%Not Available
Arrhythmia02.03.02.0010.002251%Not Available
Arthralgia15.01.02.0010.006002%
Aspartate aminotransferase increased13.03.01.0060.001500%
Asthenia08.01.01.001--Not Available
Back pain15.03.04.0050.002251%
Bladder cancer20.03.04.001; 16.08.01.0010.000783%Not Available
Blood creatine phosphokinase increased13.04.01.0010.001500%
Blood creatinine increased13.13.01.0040.002251%
Blood glucose increased13.02.02.0020.004501%Not Available
Blood pressure decreased13.14.03.0020.001500%Not Available
Blood pressure increased13.14.03.0050.001500%Not Available
Blood triglycerides increased13.12.03.001--Not Available
Breast cancer21.05.01.003; 16.10.01.0010.001500%Not Available
Cardiac failure02.05.01.0010.003718%
Cardiac failure acute02.05.01.0050.000391%Not Available
Cardiac failure congestive02.05.01.0020.004501%Not Available
Cerebral haemorrhage24.07.04.001; 17.08.01.0030.000391%Not Available
Cerebral infarction24.04.06.002; 17.08.01.0040.001566%Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 6 Pages